Paper8945688
Characteristics of materials distributed by drug companies. An evaluation of appropriateness.
Stryer D and 1 other. J Gen Intern Med, 1996. Cited by 72 papers, by iCite.
Cite this record
ConductScience Library. Characteristics of materials distributed by drug companies. An evaluation of appropriateness. Papers, record 8945688. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8945688
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Characteristics of materials distributed by drug companies. An evaluation of appropriateness.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Attitude | Major topic |
| Drug Industry | Major topic |
| Information Dissemination | Major topic |
| Interprofessional Relations | Major topic |
| United States Food and Drug Administration | Major topic |
| Advertising | |
| Conflict of Interest | |
| Cross-Sectional Studies | |
| Drug Utilization | |
| Government Regulation | |
| Humans | |
| Sampling Studies | |
| United States |
Source PubMed
Comments and corrections4
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 8945696 | Pharmaceutical marketing has real and proven value. Characteristics of materials distributed by drug companies: four points of view. | https://conductscience.org/library/papers/8945696 | PubMed |
| Comment in | 8945697 | Why do American drug companies spend more than $12 billion a year pushing drugs? Is it education or promotion? Characteristics of materials distributed by drug companies: four points of view. | https://conductscience.org/library/papers/8945697 | PubMed |
| Comment in | 8945698 | Why would anyone have expected anything else? Characteristics of materials distributed by drug companies: four points of view. | https://conductscience.org/library/papers/8945698 | PubMed |
| Comment in | 8945699 | Drug companies and information about drugs: recommendations for doctors. Characteristics of materials distributed by drug companies: four points of view. | https://conductscience.org/library/papers/8945699 | PubMed |
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7935706 | Therapeutic-class wars--drug promotion in a competitive marketplace. | N Engl J Med | 1994 | https://conductscience.org/library/papers/7935706 | PubMed |
| 2 | 1620175 | Pharmaceutical promotions--a free lunch? | N Engl J Med | 1992 | https://conductscience.org/library/papers/1620175 | PubMed |
| 3 | 7715044 | The accuracy of drug information from pharmaceutical sales representatives. | JAMA | 1995 | https://conductscience.org/library/papers/7715044 | PubMed |
| 4 | 6130249 | "Opren scandal". | Lancet | 1983 | https://conductscience.org/library/papers/6130249 | PubMed |
| 5 | 7395709 | Keeping prescription drug advertising honest. FDA's watchful eye. | Am Pharm | 1980 | https://conductscience.org/library/papers/7395709 | PubMed |
| 6 | 8413431 | A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients. | N Engl J Med | 1993 | https://conductscience.org/library/papers/8413431 | PubMed |
| 7 | 1999900 | The FDA and drug marketing expenditures. | JAMA | 1991 | https://conductscience.org/library/papers/1999900 | PubMed |
| 8 | 1620188 | Education or promotion? | N Engl J Med | 1992 | https://conductscience.org/library/papers/1620188 | PubMed |
| 9 | 8541768 | Analysis of the bureaucratic unsolicited mountainous paper heap (BUMPH) that general practitioners received in 1994. | BMJ | 1995 | https://conductscience.org/library/papers/8541768 | PubMed |
| 10 | 2231998 | The federal regulation of prescription drug advertising and promotion. | JAMA | 1990 | https://conductscience.org/library/papers/2231998 | PubMed |
| 11 | 2301192 | Impact of a drug bulletin on the knowledge, perception of drug utility, and prescribing behavior of physicians. | DICP | 1990 | https://conductscience.org/library/papers/2301192 | PubMed |
| 12 | 8214998 | The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial. | Ann Intern Med | 1993 | https://conductscience.org/library/papers/8214998 | PubMed |
| 13 | 7504540 | Pertussis immunisation and serious acute neurological illnesses in children. | BMJ | 1993 | https://conductscience.org/library/papers/7504540 | PubMed |
| 14 | 2583883 | Doctors and detailers: therapeutic education or pharmaceutical promotion? | Int J Health Serv | 1989 | https://conductscience.org/library/papers/2583883 | PubMed |
| 15 | 7901473 | Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. | Lancet | 1993 | https://conductscience.org/library/papers/7901473 | PubMed |
| 16 | 8214997 | Treatment of rheumatoid arthritis with gammalinolenic acid. | Ann Intern Med | 1993 | https://conductscience.org/library/papers/8214997 | PubMed |
| 17 | 8324433 | Interactions between a general practitioner and representatives of drug companies. | BMJ | 1993 | https://conductscience.org/library/papers/8324433 | PubMed |
| 18 | 8411572 | An economic evaluation of screening for Chlamydia trachomatis in adolescent males. | JAMA | 1993 | https://conductscience.org/library/papers/8411572 | PubMed |
| 19 | 1728655 | Policies regulating the activities of pharmaceutical representatives in residency programs. | J Fam Pract | 1992 | https://conductscience.org/library/papers/1728655 | PubMed |
| 20 | 6637804 | The regulation of prescription drug advertising. | Am Pharm | 1983 | https://conductscience.org/library/papers/6637804 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 72 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31440103 | Critical evaluation of the validity of drug promotion materials in Ethiopia. | Drug Healthc Patient Saf | 2019 | https://conductscience.org/library/papers/31440103 | PubMed |
| 28664660 | Unwarranted claims of drug efficacy in pharmaceutical sales visits: are drugs approved on the basis of surrogate outcomes promoted appropriately? | Br J Clin Pharmacol | 2017 | https://conductscience.org/library/papers/28664660 | PubMed |
| 23432773 | The cycle of bias in health research: a framework and toolbox for critical appraisal training. | Account Res | 2013 | https://conductscience.org/library/papers/23432773 | PubMed |
| 23093870 | Evaluation of drug promotional materials in a hospital setting in Nepal. | South Med Rev | 2009 | https://conductscience.org/library/papers/23093870 | PubMed |
| 22745328 | High reprint orders in medical journals and pharmaceutical industry funding: case-control study. | BMJ | 2012 | https://conductscience.org/library/papers/22745328 | PubMed |
| 21206615 | Evaluation of rationality of promotional drug literature using World Health Organization guidelines. | Indian J Pharmacol | 2010 | https://conductscience.org/library/papers/21206615 | PubMed |
| 17455990 | Characteristics and impact of drug detailing for gabapentin. | PLoS Med | 2007 | https://conductscience.org/library/papers/17455990 | PubMed |
| 16927162 | Point-counterpoint: the importance of "open access" to psychotropics for our patients. | Psychiatr Q | 2006 | https://conductscience.org/library/papers/16927162 | PubMed |
| 16861873 | Assessment of prescribing information for generic drugs manufactured in the Middle East and marketed in Saudi Arabia. | Ann Saudi Med | 2006 | https://conductscience.org/library/papers/16861873 | PubMed |
| 16050893 | Interactions between pharmaceutical representatives and doctors in training. A thematic review. | J Gen Intern Med | 2005 | https://conductscience.org/library/papers/16050893 | PubMed |
| 15994365 | Autonomy, consent, and limiting healthcare costs. | J Med Ethics | 2005 | https://conductscience.org/library/papers/15994365 | PubMed |
| 14694885 | [Psychiatrists and the pharmaceutical industry]. | Nervenarzt | 2003 | https://conductscience.org/library/papers/14694885 | PubMed |
| 12759794 | Prescribing information in 26 countries: a comparative study. | Eur J Clin Pharmacol | 2003 | https://conductscience.org/library/papers/12759794 | PubMed |
| 11885831 | Selling drugs to the public--should the UK follow the example of the US? | Br J Gen Pract | 2002 | https://conductscience.org/library/papers/11885831 | PubMed |
| 11885830 | Selling drugs to doctors--it's marketing, not education. | Br J Gen Pract | 2002 | https://conductscience.org/library/papers/11885830 | PubMed |
| 11381005 | "Educational" advertisements--I haven't seen one yet! | West J Med | 2001 | https://conductscience.org/library/papers/11381005 | PubMed |
| 10578674 | Pharmaceutical advertising revenue and physician organizations: how much is too much? | West J Med | 1999 | https://conductscience.org/library/papers/10578674 | PubMed |
| 10323794 | Direct to consumer advertising of prescription drugs. An idea whose time should not come. | BMJ | 1999 | https://conductscience.org/library/papers/10323794 | PubMed |
| 8945699 | Drug companies and information about drugs: recommendations for doctors. Characteristics of materials distributed by drug companies: four points of view. | J Gen Intern Med | 1996 | https://conductscience.org/library/papers/8945699 | PubMed |
| 8945698 | Why would anyone have expected anything else? Characteristics of materials distributed by drug companies: four points of view. | J Gen Intern Med | 1996 | https://conductscience.org/library/papers/8945698 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8945688
GET https://conductscience.org/api/papers/v1/8945688/references?page=2